Britain Accuses GlaxoSmithKline of Conspiring With Rivals Over Generics
Friday, April 19, 2013 - 23:30
in Mathematics & Economics
The antitrust authorities have accused GlaxoSmithKline of paying three competitors to delay the introduction of a generic version of an antidepressant drug.